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ABSTRACT 
Vacha is identified botanically as Acorus calmus Linn belongs to the family Araceae. In 
Pharmacological study was carried out on Wistar strain albino rats. The activity of the drug was 
analyzed under the following groups: Group I - Water control, Group II - Cholesterol control, Group 
III - Vacha Churna and Group IV - Musta Churna. Parameters like ponderal changes, 
histopathological study of organs, and biochemical parameters mainly the lipid profile were studied. 
In present study animals administered with hyperlipidaemic diet have shown increase in body 
weight in comparison to normal rats, however the observed increase is found to be statistically non-
significant. Both the test drugs non-significantly attenuated the body weight, among them the 
magnitude of decreased bodyweight is more in Vacha treated group. In present study 
administration of hyperlipidaemic diet did not affect the weight if heart, liver and kidney to 
significant extent in comparison to normal rats. In test drug treated groups also the weight of these 
organs not affected to significant extent. Administration of Vacha churna and Musta churna did not 
affect serum lipid parameters in comparison to cholesterol control rats except on serum HDL 
cholesterol in which moderate attenuation was observed. The test drugs contrary to the expectation 
did not significantly lower neither the cholesterol nor the triglyceride level in the serum.  
KEYWORDS: Anti-Hyperlipidaemic Activity, Vacha, Acorus calamus Linn.), Musta Cyperus  
rotundus L. 
INTRODUCTION
The earliest Indian records are Vedas and the 
world’s oldest known pharmacological and therapeutic 
writing comes from India. From that day lots of 
references are available regarding the testing of the 
drugs and foods on the animal for the safety of the 
mankind. In Charaka Samhita numerous references 
find their way to depict these procedures e.g. in Siddhi 
sthana Adhyaya 6/79 - 80 references to testing on 
animals can be found. Sushruta Samhita has dealt with 
this by allotting a separate chapter on Yogya Vidhi (Su. 
Su. 9), in which it is said that any procedure which is 
expected to be performed on human being should 
undergo trials on animals or other things, having same 
characteristics and in Kalpasthana there is similar 
discussion dealing with the observations of animal 
experiments. Acharya Vagbhata has also described 
them in more or less similar manner. 
Pharmacology, the science of drug action, has 
helped to elucidate many basic physiological and 
pathological mechanisms in health and disease. Various 
animal experimental models have been designed to 
study the effect of drugs on living organisms and 
isolated tissues. These give an insight about where and 
how a drug acts the mode of action of a drug, its effect 
on various body systems and probable adverse effects 
before administration of a drug. Therefore, the object of 
pharmacology is to provide such scientific data in 
animals as well as humans, which forms the basis of 
rational therapeutics  
AIMS AND OBJECTIVES 
1. Evaluation of Vacha churna to assess its effect on 
lipid profile of albino rats for possible use as anti- 
hyperlipidaemic drug. 
2. To compare its efficacy as anti-hyperlipidaemic drug 
with Musta churna which is considered as standard 
Ayurved hypolipidaemic drug.  
3. To provide experimental basis to the clinical 
findings. 
MATERIALS AND METHODS 
Animals 
Wistar strain albino rats of either sex weighing 
140 to 240 g were obtained from animal house 
attached to the Pharmacology Laboratory, I.P.G.T. & 
R.A., G.A.U., Jamnagar. Animals were exposed to natural 
day and night cycles with ideal laboratory condition in 
terms of ambient temperature (22 ± 2ºC) and humidity 
(50 – 60%). They were fed with Amrut brand rat pellet 
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feed supplied by Pranav Agro Industries and tap water 
given ad libitum. All procedures and experiments were 
conducted in day time according to specification of the 
Indian National Science Academy (INSA). The 
experiments were carried out after obtaining the 
permission of Institutional Animal Ethics Committee 
(Approval number IAEC 09-10/05MD 03). 
Dose fixation and schedule 
The dose of the formulations was calculated by 
extrapolating the therapeutic dose to rat dose on the 
basis of body surface area ratio by referring to the table 
of Paget and Barnes (1969)1. 
(a)Human dose × conversion factor (0.018) for rat = 'x' 
/ 200 g 
(b) 'X' × 5 = 'Y' / kg dose 
Human dose – 6g/day 
So, by calculating this way, the rat dose of Vacha churna 
is 100mg /kg and Musta churna is 550mg /kg. 
Preparation of test drug 
The drug was crushed into fine powder and 
made in to fine suspension in distilled water to obtain 
suitable concentration to administer at a volume of 
1ml/200g body wt., while the animals of control group 
were given only tap water in an equal volume. The drug 
solutions and tap water were administered with the 
help of gastric catheter sleeved to syringe. 
Parameters studied 
1. Ponderal changes 
Body weight, Weight of liver, heart and kidney. 
2. Histopathology study of liver, heart, kidney and 
aorta. 
3. Biochemical parameters 
Serum total cholesterol, serum triglyceride, 
serum HDL cholesterol, Serum LDL cholesterol, serum 
VLDL cholesterol, blood sugar, blood urea, serum 
creatinine, serum total protein, serum albumin, serum 
globulin, A/G ratio, S.GOT, S.GPT and serum alkaline 
phosphatase. 
Procedures for biochemical parameters estimation 
The requisite quantity of serum was fed to the 
auto analyzer, which was automatically drawn in to the 
instrument for estimating different parameters. 
References given in the kit literature mentioning the 
basis of the methods on which test procedures have 
been evolved are mentioned along with each of the test 
mentioned below. 
Blood glucose (GOD - POD method, end point)2, 
Blood urea (Urease - GLDH - Fixed time, Kinetic, 
enzymatic method)3, serum creatinine (Modified Jaffe’s 
reaction)4, serum total cholesterol (CHOD – PAP, end 
point)5, Serum HDL cholesterol (Trinder reaction)6, 
serum triglyceride (GOP – PAP method, end point)7, 
serum total protein (Biurate Method, End method)8, 
serum albumin (BCG Dye method, end point)9, serum 
globulin (Serum globulin was calculated from serum 
protein and serum albumin values), serum alkaline 
phosphatase (IFCC Method, Kinetic method)10, 
SGOT(IFCC method without (Pyridoxal Phosphate)11, 
SGPT (IFCC method, kinetic without Pyridoxal 
Phosphate).12 
OBSERVATIONS & RESULTS 
PONDERAL CHANGES 
A) Effect on body weight 
Table 1: Effect of Vacha churna and Musta churna on body weight of hyper hyperlipidaemic albino rats 
Groups Dose 
(mg/kg) 
Body Weight 
Initial body 
wt. 
Final body 
wt. 
Weight 
gain 
% change % change 
of weight 
% 
change 
Water 
control 
Q.S. 192.33 ± 
02.39 
221.33 ± 
09.52 
32.67 ± 
05.90 
--- 16.63 ± 
03.74 
--- 
Cholesterol 
Control 
Q.S. 182.17 ± 
17.28 
210.00 ± 
11.41 
27.80 ± 
06.78 ↑ 
14.81 ↓ 17.56 ± 
05.28 
05.60 ↑ 
Vacha 100 167.00 ± 
05.43 
187.67 
± 5.35 
20.67± 
6.9 
25.72 ↓ 12.85± 
4.35 
26.82 ↓ 
Musta 550 173.83 ± 
08.19 
197.67 
± 7.47 
24.17± 
4.78 
13.15 ↓ 14.30± 
3.11 
18.56 ↓ 
Data: Mean ± SEM 
Data related to the effect of test drugs on body weight of hyper hyperlipidaemic albino rats has been presented 
in Table - 1. Administration of hyperlipidaemic diet leads to marginal but statistically non-significant increase in body 
weight in comparison to normal rats. An apparent and statistically non-significant decrease in body weight was observed 
in both test drug administered groups in comparison to cholesterol control group. This indicates presence of weak to 
moderate body weight reducing activity in the test drugs. 
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B) Effect on weight of liver 
Table 2 :Effect of Vacha churna and Musta churna on liver weight of hyper hyperlipidaemic albino rats 
Groups 
Dose 
(mg/kg) 
Weight of liver (g) 
Absolute weight (g) 
Relative weight 
(g/100 g body wt)  
% change 
Water control Q.S. 8.72 ± 0.66 3.86 ± 0.20 -- 
Cholesterol Control Q.S. 6.67 ± 0.35 3.25 ± 0.18 15.80 ↓ 
Vacha 100 6.28 ± 0.33 3.43 ± 0.10 05.53↑ 
Musta 550 7.07 ± 0.46 3.57 ± 0.16 10.00↑ 
Data: Mean ± SEM 
The data related to the effect of test drug on liver weight have been shown in Table- 2. Administration of 
hyperlipidaemic diet leads to marginal but statistically non-significant decrease in weight of liver in comparison to 
normal rats. Administration of test drugs did not affect the weight of liver to significant extent in comparison to 
cholesterol control rats.  
C) Effect on weight of heart
Table 3: Effect of Vacha churna and Musta churna on heart weight of hyper hyperlipidaemic albino rats 
Groups 
Dose 
(mg/kg) 
Weight of Heart (g) 
Absolute weight 
(g) 
Relative weight  
(g/100 g body wt) 
% change 
Water control Q.S. 0.71±0.03 0.32 ± 0.02 --- 
Cholesterol Control Q.S. 0.65±0.03 0.32 ± 0.02 --- 
Vacha 100 0.63±0.02 0.35 ± 0.02 10.00↑ 
Musta 550 0.62±0.03 0.31 ± 0.01 --- 
Data: Mean ± SEM 
The data related to the effect of test drug on heart weight have been shown in Table- 3. Administration of 
hyperlipidaemic diet did not affect the heart weight to significant extent in comparison to normal rats. 
Administration of Vacha leads to a marginal increase in weight of heart which is found to be statistically non-
significant. Administration of Musta did not affect the weight of the heart to significant extent. 
D) Effect on weight of kidney 
Table 4: Effect of Vacha churna and Musta churna on kidney weight of hyperlipidaemic albino rats 
Groups Dose (mg/kg) 
Weight of kidney (g) 
Absolute weight (g) 
Relative weight  
(g/100 g body wt) 
% change 
Water control Q.S. 1.43±0.07 0.64±0.02 --- 
Cholesterol Control Q.S. 1.27±0.08 0.61±0.01 5.0  
Vacha 100 1.21±0.05 0.66±0.02 8.0 ↑ 
Musta 550 1.27±0.07 0.64±0.03 5.0 ↑ 
Data: Mean ± SEM ↑ - Increase  - Decrease 
The data related to the effect of test drug on kidney weight have been shown in Table- 4. Administration of 
hyperlipidaemic diet leads to marginal but statistically non-significant decrease in weight of kidney in comparison 
to normal rats. Administration of test drugs leads to marginal but statistically non-significant increase in weight of 
kidney in comparison to cholesterol control rats.  
BIOCHEMICAL PARAMETERS 
A) Effect on serum cholesterol
Table 5: Effect of Vacha churna and Musta churna on serum total cholesterol level in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Total cholesterol (mg/dl) % change 
Water control Q.S. 51.83 ± 03.32 --- 
Cholesterol Control Q.S. 77.00 ± 05.54** 48.56 #↑  
Vacha 100 71.50 ± 04.90 07.14© ↓ 
Musta 550 72.50 ± 04.40 05.84 © ↓ 
Data: Mean ± SEM ↓ - Decrease **P<0.01 
(# - In comparison to normal control) (© - In comparison to cholesterol control group) 
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Data pertaining to effect of test drugs on total cholesterol level have been provided in Table - 5. An 
apparent and statistically significant increase in total cholesterol level was observed in cholesterol control rats in 
comparison to normal rats. Administration of Vacha and Musta lead to statistically non-significant decrease in total 
cholesterol level in comparison to cholesterol control rats.  
B) Effect on serum triglycerides 
Table 6: Effect of Vacha churna and Musta churna on serum triglycerides level in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum triglycerides (mg/dl) % change 
Water control Q.S. 106.83 ±17.37 --- 
Cholesterol Control Q.S. 137.33±20.03 28.55 ↑ 
Vacha 100 149.67± 24.23 08.98 ↑ 
Musta 550 131.67±21.64 04.12 ↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease 
Data pertaining to effect of test drugs on total tryglyceride level have been provided in Table - 6. An 
apparent and statistically non-significant increase in serum triglyceride level was observed in cholesterol control 
rats in comparison to normal rats. Administration of Vacha lead to statistically non-significant increase in serum 
triglyceride level where as administration of Musta lead to non-significant decrease in comparison to cholesterol 
control rats.  
C) Effect on serum HDL
Table 7: Effect of Vacha churna and Musta churna on serum HDL cholesterol level in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum HDL (mg/dl) % change 
Water control Q.S. 29.67±3.08  
Cholesterol Control QS 49.17±4.13*** 65.72 ↑ 
Vacha 100 39.83±4.37 18.99↓ 
Musta 550 43.17±0.95 12.20↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease ***P<0.01 
Data pertaining to effect of test drugs on HDL cholesterol level have been provided in Table - 7. An apparent 
and statistically significant increase in HDL cholesterol level was observed in cholesterol control rats in comparison 
to normal rats. Administration of Vacha and Musta lead to statistically non-significant decrease in HDL cholesterol 
level in comparison to cholesterol control rats.  
D) Effect on serum VLDL 
Table 8: Effect of Vacha churna and Musta churna on serum VLDL cholesterol level in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum VLDL cholesterol level (mg/dl) % change 
Water control Q.S. 21.37 ± 03.47 -- 
Cholesterol Control Q.S. 31.13 ± 04.82 45.67 ↑ 
Vacha 100 29.93 ± 04.84 03.72 ↓ 
Musta 550 26.33 ± 04.33 15.41 ↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease 
Data pertaining to effect of test drugs on VLDL level have been provided in Table - 8. An apparent and 
statistically non-significant increase in VLDL level was observed in cholesterol control rats in comparison to normal 
rats. Administration of Vacha and Musta lead to statistically non-significant decrease in VLDL level in comparison to 
cholesterol control rats.  
E) Effect on serum glucose 
Table 9: Effect of Vacha churna and Musta churna on serum glucose level in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum glucose (mg/dl) % change 
Water control Q.S. 136.17 ± 04.14  
Cholesterol Control Q.S. 094.33 ± 04.29*** 30.72 ↓ 
Vacha 100 121.83 ± 07.76** 29.15 ↑ 
Musta 550 101.33 ± 10.01 07.42 ↑ 
Data: Mean ± SEM ↑ - Increase  - Decrease ***P<0.001 **P<0.05 
Data pertaining to effect of test drugs on serum glucose level have been provided in Table - 9. An apparent 
and statistically significant decrease in serum glucose level was observed in cholesterol control rats in comparison 
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to normal rats. Administration of Vacha lead to statistically significant increase in serum glucose level in 
comparison to cholesterol control rats where as Musta lead to non-significant increase in serum glucose level.  
F) Effect on serum proteins: 
Table 10: Effect of Vacha churna and Musta churna on serum protein level in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum proteins (mg/dl) % change 
Water control Q.S. 7.18 ± 0.27  
Cholesterol Control Q.S. 8.40 ± 0.24** 17.00 ↑ 
Vacha 100 7.17 ± 0.63 14.64 ↓ 
Musta 550 7.30 ± 0.56 13.09 ↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease **P<0.01 
Data pertaining to effect of test drugs on serum total protein level have been provided in Table - 10. An 
apparent and statistically significant increase in serum total protein level was observed in cholesterol control rats 
in comparison to normal rats. Administration of Vacha and Musta lead to statistically non-significant decrease in 
serum total protein level in comparison to cholesterol control rats.  
G) Effect on serum albumin 
Table 11: Effect of Vacha churna and Musta churna at two dose level on serum albumin level in 
hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum albumin(mg/dl) % change 
Water control Q.S. 3.78 ± 0.23 --- 
Cholesterol Control Q.S. 4.37 ± 0.12* 15.61 ↑ 
Vacha 100 4.12 ± 0.11 05.72 ↓ 
Musta 550 4.17 ± 0.11 04.57 ↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease  *P<0.05 
Data pertaining to effect of test drugs on serum albumin level have been provided in Table - 11. An 
apparent and statistically significant increase in serum albumin level was observed in cholesterol control rats in 
comparison to normal rats. Administration of Vacha and Musta lead to statistically non-significant decrease in 
serum albumin level in comparison to cholesterol control rats.  
H) Effect on serum globulin 
Table 12: Effect of Vacha churna and Musta churna on serum globulin level in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum globulin (mg/dl) % change 
Water control Q.S. 3.40 ± 0.14 -- 
Cholesterol Control Q.S. 4.03 ± 0.16* 18.53↑ 
Vacha 100 3.77 ± 0.26 06.45↓ 
Musta 550 3.57 ± 0.19 11.41↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease  *P<0.05 
Data pertaining to effect of test drugs on serum globulin level have been provided in Table - 12. An 
apparent and statistically significant increase in serum globulin level was observed in cholesterol control rats in 
comparison to normal rats. Administration of Vacha and Musta lead to statistically non-significant decrease in 
serum globulin level in comparison to cholesterol control rats.  
I) Effect on serum A/G ratio: 
Table 13: Effect of Vacha churna and Musta churna serum A/G ratio in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum A/G ratio (mg/dl) 
Water control Q.S. 1.10 ± 0.08 
Cholesterol Control Q.S. 1.12 ± 0.05 
Vacha 100 1.13 ± 0.08 
Musta 550 1.22 ± 0.08 
Data: Mean ± SEM ↑ - Increase 
Data pertaining to effect of test drugs on serum A:G ratio have been provided in Table - 13. Hyperlipidaemic 
diet did not affect the A/G ratio. Administration of test drugs did not affect the serum A:G ratio to significant extent.  
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J) Effect on blood urea 
Table 14: Effect of Vacha churna and Musta churna at two dose level on serum urea in hyperlipidaemic 
albino rats 
Groups Dose (mg/kg) Serum urea level (mg/dl) % change 
Water control Q.S. 35.33 ± 2.51 --- 
Cholesterol Control Q.S. 47.33 ± 2.94** 33.96 ↑ 
Vacha 100 36.83 ± 2.74* 22.18 ↓ 
Musta 550 33.33 ± 1.45*** 29.57 ↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease ***P<0.001 **P<0.01 **P<0.05 
Data pertaining to effect of test drugs on serum urea level have been provided in Table - 14. An apparent 
and statistically significant increase in serum urea level was observed in cholesterol control rats in comparison to 
normal rats. Administration of Vacha and Musta significantly attenuated the hyperlipidaemic diet induced elevation 
of serum urea level in comparison to cholesterol control rats.  
K) Effect on serum creatinine 
Table 15: Effect of Vacha churna and Musta churna on serum creatinine in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum creatinine level (mg/dl) % change 
Water control Q.S. 0.57 ± 0.02 --- 
Cholesterol Control Q.S. 0.80 ± 0.03*** 40.35 ↑ 
Vacha 100 0.72 ± 0.05 10.00↓ 
Musta 550 0.68 ± 0.03* 15.00↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease ***P<0.001 *P<0.05 
Data pertaining to effect of test drugs on serum creatinine level have been provided in Table - 15. An 
apparent and statistically significant increase in serum creatinine level was observed in cholesterol control rats in 
comparison to normal rats. Administration of Vacha decreased it non-significantly whereas Musta decreased it to 
significant extent in comparison to cholesterol control rats.  
L) Effect on S.GOT activity 
Table 16: Effect of Vacha churna and Musta churna on S.GOT activity in hyperlipidaemic albino rats 
Group Dose (mg/kg) S.GOT (IU) % change 
Water control Q.S. 175.00 ± 12.06 --- 
Cholesterol Control Q.S. 149.40 ± 18.88 14.62 ↓ 
Vacha 100 190.17 ± 24.27 27.28 ↑ 
Musta 550 143.00 ± 18.80 04.28 ↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease 
Data pertaining to effect of test drugs on S.GOT activity have been provided in Table - 16. An apparent and 
statistically non-significant decrease in S.GOT activity was observed in cholesterol control rats in comparison to 
normal rats. Administration of Vacha increased it to non-significant extent while in Musta administered group the 
values were similar to the values observed in cholesterol control rats. 
M) Effect on S.GPT 
Table 17: Effect of Vacha churna and Musta churna on S.G.P.T. activity in hyperlipidaemic albino rats 
Group Dose (mg/kg) S.G.P.T. activity (IU) % change 
Water control Q.S. 72.17 ± 05.16 --- 
Cholesterol Control Q.S. 128.5 ± 18.78* 78.05↑ 
Vacha 100 81.50 ± 14.02* 36.57↓ 
Musta 550 69.67 ± 13.12* 45.78↓ 
Data: Mean ± SEM ↑ - Increase  - Decrease *P<0.05 
Data pertaining to effect of test drugs on S.GPT activity have been given in Table - 17. An apparent and 
statistically significant increase in S.GPT activity was observed in cholesterol control rats in comparison to normal 
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rats. Administration of Vacha and Musta significantly attenuated the observed S.GPT activity elevation in 
comparison to cholesterol control rats.  
N) Effect on serum alkaline phosphatase activity 
Table 18: Effect of Vacha churna and Musta churna on serum ALP activity in hyperlipidaemic albino rats 
Groups Dose (mg/kg) Serum ALP activity (IU) % change 
Water control Q.S. 346.83 ± 39.61 ---- 
Cholesterol Control Q.S. 544.00 ±31.50* 56.84 ↑ 
Vacha 100 688.00 ± 49.57 26.47 ↑ 
Musta 550 562.40 ± 67.78 03.30 ↑ 
Data: Mean ± SEM ↑ - Increase *P<0.05 
Data pertaining to effect of test drugs on ALP 
activity have been presented in Table - 18. An apparent 
and statistically significant increase in ALP activity was 
observed in cholesterol control rats in comparison to 
normal rats. Administration of Vacha caused a 
moderate but statistically non-significant elevation of 
ALP activity in comparison to cholesterol control rats. 
In Musta administered group only a non-significant 
marginal elevation was observed in comparison to 
cholesterol control rats.  
EFFECT ON CYTOARCHITECTURE OF DIFFERENT 
ORGANS 
1. Liver: Examination of section of liver from 
hyperlipidaemic diet given rats did not reveal any 
remarkable change in the cytoarchitecture in 
comparison to sections from the normal control 
rats. In Vacha and Musta administered 
hyperlipidaemic diet given rats also normal 
cytoarchitecture was observed. Plate – 5.1 & 5.2 
contains photomicrographs of representative 
sections from different groups.  
2. Kidney: Examination of kidney sections obtained 
from hyperlipidaemic diet given rats showed mild 
fatty changes in few rats and normal 
cytoarchitecture in the remaining rats. In kidney 
sections obtained from Vacha and Musta 
administered and hyperlipidaemic diet given rats 
normal cytoarchitecture was observed. Plate – 5.3 & 
5.4 contains photomicrographs of representative 
sections from different groups.  
3. Heart: Examination of section of heart from 
hyperlipidaemic diet given rats did not reveal any 
remarkable change in the cytoarchitecture in 
comparison to sections from the normal control 
rats. In Vacha and Musta administered 
hyperlipidaemic diet given rats also normal 
cytoarchitecture was observed. Plate – 5.5 & 5.6 
contains photomicrographs of representative 
sections from different groups.  
4. Aorta: Examination of sections of aorta from 
hyperlipidaemic diet given rats did not reveal any 
remarkable change in the cytoarchitecture in 
comparison to sections from the normal control 
rats. In Vacha and Musta administered 
hyperlipidaemic diet given rats also normal 
cytoarchitecture was observed. Plate – 5.7 & 5.8 
contains photomicrographs of representative 
sections from different groups.  
CONCLUSION 
The both drugs though were not very effective 
in lowering the hyperlipidaemic diet induced elevated 
lipid levels are quite effective in attenuating the 
hyperlipidaemia induced functional disorders. In test 
drug treated groups also the weight of these organs not 
affected to significant extent. Administration of Vacha 
churna and Musta churna did not affect serum lipid 
parameters in comparison to cholesterol control rats 
except on serum HDL cholesterol in which moderate 
attenuation was observed. The test drugs contrary to 
the expectation did not significantly lower neither the 
cholesterol nor the triglyceride level in the serum.  
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